|
Invited Speakers:
|
|
2015 Confirmed Speakers:
- Keith Foster, VP Scientific Affairs, Syntaxin, an Ipsen Company
- Johnson Varghese, Senior Director Analytical Development, Shire
- Jonathan Wrigley, Associate Director, AstraZeneca
- Ulrich Rümenapp, Head of Biotech Projects, Contract Manufacturing Biotech, Bayer
- Oliver Chao, Head of Emerging Biomedical Sciences, Sanofi
- Justyna Jozefczuk, Principal Scientist, Novartis
- Kirsten McGuire, Stem Cell Development Specialist, Novo Nordisk
- Orit Aharonovitz, Head of Molecular & Cell Biology, Teva Pharmaceuticals
- Dylan Jones, Principal Scientist, Genzyme
- Rob de Jong, Assistant Director CMC Research & Protein Chemistry, Genmab
- Wibke Lembke, Associate Director Development, Covagen
- Peter Becker, Director, Cell Culture, Novo Nordisk
- Darya Burakov, Associate Director, Regeneron
- Martin Bertschinger, Senior Team Leader, Glenmark Pharmaceuticals
- Mark Federspiel, Director, Viral Vector Production Laboratory, Mayo Clinic
- John Masters, Professor of Experimental Pathology, University College London
- Stefan Przyborski, Professor of Cell Technology, Durham University
- Nicolas Mermod, Professor, Ecole Polytechnique Federal de Lausanne
- Christiane Niederlaender, Quality Assessor, MHRA
- Julian Morris, Director, CPACT and Visiting Professor, University of Strathclyde
- Alvin Nienow, Emeritus Professor of Biochemical Engineering, University of Birmingham
- Sam Janes, Professor of Respiratory Medicine, University College London
|
|